Bladder Cancer and Genetic Mutations

  title={Bladder Cancer and Genetic Mutations},
  author={X. Zhang and Y. Zhang},
  journal={Cell Biochemistry and Biophysics},
  • X. Zhang, Y. Zhang
  • Published 2015
  • Biology, Medicine
  • Cell Biochemistry and Biophysics
  • The most common type of urinary bladder cancer is called as transitional cell carcinoma. The major risk factors for bladder cancer are environmental, tobacco smoking, exposure to toxic industrial chemicals and gases, bladder inflammation due to microbial and parasitic infections, as well as some adverse side-effects of medications. The genetic mutations in some chromosomal genes, such as FGFR3, RB1, HRAS, TP53, TSC1, and others, occur which form tumors in the urinary bladder. These genes play… CONTINUE READING
    33 Citations
    Prognostic factors of non-muscle invasive bladder cancer: a study based on next-generation sequencing
    • PDF
    Structural Alterations in Human Fibroblast Growth Factor Receptors in Carcinogenesis
    • 3
    HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
    • 10
    • PDF


    Bladder cancer.
    • H. Ozen
    • Medicine
    • Current opinion in oncology
    • 1998
    • 1,655
    Concurrent Alterations in TERT, KDM6A, and the BRCA Pathway in Bladder Cancer
    • 73
    • PDF
    Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
    • G. Netto
    • Medicine
    • Nature Reviews Urology
    • 2012
    • 118
    • PDF
    p53 mutations in human bladder cancer: Genotypic versus phenotypic patterns
    • 268
    American Association for Cancer Research
    • 360
    • PDF
    • 68 Cell Biochem Biophys
    • 2015
    Are we there yet? Review
    • Nature Reviews Urology, 9, 41–51. Published online 13 Dec 2011. Cell Biochem Biophys
    • 2015